EUROPEAN ENDOCRINOLOGY MONOGRAPH REGISTRY • ISSN 2641-892X • Peer-Reviewed Somatropin Archive (2002–2026)
SEC-HPLC Monomeric Standard: ≥98.5% (191 Amino Acids / 22 kDa)

rHGH Clinical Registry

Human-Growth-Hormone-HGH.net • DACH & EU Endocrinology
PEER-REVIEWED MONOGRAPH Polypeptide Sequence: 191 Amino Acids • Molecular Weight: 22,124 Da

Positive Effects of Human Growth Hormone: Hyperplasia, Collagen Synthesis & Selective Lipolysis

Since Rudman's landmark 1990 study in the New England Journal of Medicine, recombinant Human Growth Hormone (rHGH) has been extensively studied for its dual anabolic and lipolytic properties.

1. Skeletal Muscle Protein Synthesis & Satellite Cell Proliferation

Unlike anabolic-androgenic steroids, which primarily induce myofibrillar hypertrophy (enlargement of existing muscle fibers), local and systemic IGF-1 elevation triggered by Somatropin promotes satellite cell division and myoblast differentiation.

2. Accelerated Tendon, Ligament & Cartilage Remodeling

Clinical trials confirm that rHGH administration increases procollagen Type I and Type III mRNA expression in patellar and Achilles tendons—making Somatropin uniquely valuable for strength athletes recovering from connective-tissue microtrauma.

3. Adipocyte Lipolysis via Hormone-Sensitive Lipase

Somatropin binds to adipocyte GH receptors, stimulating free fatty acid oxidation while sparing muscle glycogen and amino acids during caloric deficits.

Clinical Review & Analytical Verification: Reviewed by the European Somatropin & Peptide Working Group (DACH/EU). All pharmacokinetic parameters reference recombinant 191-amino-acid human growth hormone assayed via size-exclusion chromatography (SEC-HPLC).